NATCOPHARM — NATCO Pharma Limited

NSE · AI Signal & Stock Analysis · Bearish

As of Aug 14 2026, 6:50 PM, AkshayaAI's signal for NATCOPHARM is Bearish ↓ (extreme move); technical trend down-trend; trading at ₹920.10 (-1.51% today); neutral (RSI 42).

Data as of Aug 14 2026, 6:50 PM. Informational analytics only — not investment advice.

Key metrics

What's driving the signal

• -Strong Down
• RSI is neutral
• Relative volume 0.14× (light)
• 24% below its 52-week high
• 16% above its 52-week low

Frequently asked about NATCOPHARM

What is AkshayaAI's signal for NATCOPHARM today?

As of Aug 14 2026, 6:50 PM, AkshayaAI's signal for NATCOPHARM (NATCO Pharma Limited) is Bearish with a extreme move, and its technical trend is down-trend. The composite score and full factor breakdown are available to signed-in members.

Is NATCOPHARM overbought or oversold right now?

NATCOPHARM's RSI is neutral (RSI 42). A reading above 70 is typically overbought and below 30 oversold.

Where is NATCOPHARM in its 52-week range?

NATCOPHARM is trading about 24% below its 52-week high and 16% above its 52-week low as of Aug 14 2026, 6:50 PM.

What is NATCOPHARM's market capitalisation?

NATCOPHARM's market capitalisation is ₹16,176 Cr as of Aug 14 2026, 6:50 PM.

What sector is NATCOPHARM in?

NATCOPHARM is classified under Drug Manufacturers - Specialty & Generic in AkshayaAI's taxonomy.

AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 6:50 PM and may not reflect real-time prices. Always do your own research. How these signals work →